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The Mycobacterium tuberculosis acyl-coenzyme A (CoA) carboxylases provide the building blocks for de novo
fatty acid biosynthesis by fatty acid synthase I (FAS I) and for the elongation of FAS I end products by the FAS
II complex to produce meromycolic acids. The M. tuberculosis genome contains three biotin carboxylase
subunits (AccA1 to -3) and six carboxyltransferase subunits (AccD1 to -6), with accD6 located in a genetic locus
that contains members of the FAS II complex. We found by quantitative real-time PCR analysis that the
transcripts of accA3, accD4, accD5, and accD6 are expressed at high levels during the exponential growth
phases of M. tuberculosis in vitro. Microarray analysis of M. tuberculosis transcripts indicated that the transcripts for accA3, accD4, accD5, accD6, and accE were repressed during later growth stages. AccD4 and AccD5
have been previously studied, but there are no reports on the function of AccD6. We expressed AccA3 (␣3) and
AccD6 (␤6) in E. coli and purified them by affinity chromatography. We report here that reconstitution of the
␣3-␤6 complex yielded an active acyl-CoA carboxylase. Kinetic characterization of this carboxylase showed that
it preferentially carboxylated acetyl-CoA (1.1 nmol/mg/min) over propionyl-CoA (0.36 nmol/mg/min). The
activity of the ␣3-␤6 complex was inhibited by the  subunit. The ␣3-␤6 carboxylase was inhibited significantly
by dimethyl itaconate, C75, haloxyfop, cerulenin, and 1,2-cyclohexanedione. Our results suggest that the ␤6
subunit could play an important role in mycolic acid biosynthesis by providing malonyl-CoA to the FAS II
complex.

subunit, and there are six ␤ subunits (accD1 to -D6) in the
genome of the pathogen (6).
Previously, the catalytic activities of the ␣3, ␤4, and ␤5 subunits were studied (10, 11, 22, 24). However, the levels of
expression of the various subunits have not been examined.
Our analysis of transcripts from M. tuberculosis cells indicate
that the ␣3, ␤4, ␤5, ␤6, and ε ORFs are the main subunits
regulated during cell growth. To determine whether the highly
expressed ␤6 subunit possessed enzymatic activity and to assess
its substrate specificity, we expressed and purified the ␤6 subunit and reconstituted it with the purified ␣3 subunit. We
report that an active acyl-CoA carboxylase was reconstituted
with the purified ␤6 and ␣3 subunits and that it preferentially
carboxylated acetyl-CoA over propionyl-CoA. This is the first
report showing that ␤6, which is a member of a fatty acid
synthase II (FAS II) gene locus, is a functional carboxyltransferase of the acyl-CoA carboxylase in M. tuberculosis, and these
results suggest that ␤6 might make a significant contribution to
mycolate biosynthesis.

Tuberculosis causes 2 million deaths each year, according to
the World Health Organization. Mycobacterium tuberculosis,
the pathogen that causes the disease, infects 8 million people
each year and is one of the world’s deadliest pathogens (9).
The ongoing AIDS pandemic has developed a deadly synergy
with tuberculosis, which is the leading cause of death among
AIDS patients (2). Multidrug-resistant M. tuberculosis strains
have been emerging rapidly (9), and the need for identifying
novel drug targets in this pathogen has become urgent. The cell
wall of M. tuberculosis is lipid enriched and acts as an impermeable barrier to many common broad-spectrum antibiotics
(14).
The first committed step of fatty-acid biosynthesis, which is
the biotin-dependent carboxylation of acyl-coenzyme A (CoA)
to produce malonyl-CoA and methylmalonyl-CoA, is catalyzed
by the acyl-CoA carboxylase. The reaction consists of two catalytic steps, which involve the biotin carboxylase and the carboxyltransferase (8). In M. tuberculosis, the biotin carboxylation step is catalyzed by the ␣ subunit; there are three open
reading frames (ORFs) that can encode the ␣ subunit (accA1
to -A3) in the genome. Carboxyl transfer is catalyzed by the ␤

MATERIALS AND METHODS
Bacterial strains and culture conditions. M. tuberculosis H37Rv was grown in
Middlebrook 7H9 (supplemented with 0.05% Tween 80, 10% oleic acid-albumindextrose-catalase enrichment, and 0.2% glycerol). All subcloning procedures were
carried out in Escherichia coli DH5␣ according to the method of Sambrook et al.
Recombinant-protein expression was performed in E. coli BL21 Star (DE3) (Invitrogen). Luria-Bertani broth was used for all E. coli cultures, and when required,
antibiotics were added to the culture at the following concentrations: kanamycin, 50
g/ml; carbenicillin, 50 g/ml; chloramphenicol, 34 g/ml.
Chemicals and reagents. [14C]sodium bicarbonate (50 Ci · mol⫺1) was purchased from American Radiolabeled Chemicals, Inc. All other chemicals were
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TABLE 1. qPCR primers used in this study
Primer sequencea

Product size (bp)

Reference

accA1 (Rv2501c)

F: 5⬘-GCACGGTGGTCGGCAGTGATTA-3⬘
R: 5⬘-CGTGCGCAATCACCTTGGTGA-3⬘
F: 5⬘-TCGCACACGGCTTCACGGTT-3⬘
R: 5⬘-TGACAGTGCCACCAGGTGAACG-3⬘
F: 5⬘-CTGGATCGAGACCGAGTGGAATA-3⬘
R: 5⬘-AGAGGTTCGCCGTCGGTAAA-3⬘
F: 5⬘-AAGGGAGCGCATTTCATCGAGC-3⬘
R: 5⬘-TGCAGGAACAGCAGCGGAATC-3⬘
F: 5⬘-TTCTTACACAACACCACCGGCTACA-3⬘
R: 5⬘-CATGCTTGATCATCCCGCCTT-3⬘
F: 5⬘-CGCGATCGTGTTCCGAGACA-3⬘
R: 5⬘-CGACAATCCCCGACTTCAGTAGGT-3⬘
F: 5⬘-CCGGAAGAGCTTCGTCGAGAATT-3⬘
R: 5⬘-GATGACGGCATCGATGAACCC-3⬘
F: 5⬘-CGGCTCCTCGACGACGAATT-3⬘
R: 5⬘-CGAACCCCACCACGATGTTTT-3⬘
F: 5⬘-TTCGACGAGTTCCAGGCCAATT-3⬘
R: 5⬘-AGCGGGTTGTTGGCCAGTACAC-3⬘
F: 5⬘-AGCCCCACATCGAGATACTGCG-3⬘
R: 5⬘-ATACTGCCCAGCACCGCGAT-3⬘
F: 5⬘-CCGATGACGACGAGGAGATC-3⬘
R: 5⬘-CGGAGGCCTTGTCCTTTTC-3⬘

54

This study

86

This study

57

This study

59

This study

67

This study

92

This study

85

This study

67

This study

95

This study

76

This study

51
51

12

accA2 (Rv0973c)
accA3 (Rv3285)
accD1 (Rv2502c)
accD2 (Rv0974c)
accD3 (Rv0904c)
accD4 (Rv3799c)
accD5 (Rv3280)
accD6 (Rv2247)
accE (Rv3281)
sigA (Rv2703)
a

F, forward primer; R, reverse primer.

purchased from Sigma and Fisher Scientific. All media were purchased from
Difco. Nucleotide primers were synthesized by Integrated DNA Technologies,
Inc.
qPCR analysis. Total RNA (5 g) was treated with 2.5 units of DNase I
(Ambion) according to the manufacturer’s instructions. First-strand cDNA was
synthesized using SuperScript III and 6 g of random primers (Invitrogen). The
cDNA was purified with a QIAquick PCR purification kit (QIAGEN). The
primers used are listed in Table 1. The primers corresponding to each ORF were
designed to amplify less than 100 bp of product. Quantitative real-time PCR
(qPCR) was performed in triplicate with three different concentrations of the
diluted cDNAs (0.5 ng, 1 ng, and 5 ng) and 25 l of iQ SyBr Green Supermix (2⫻
Premixture; Bio-Rad) in a total volume of 50 l. The qPCR was carried out at
95°C for 20 s and 60°C for 20 s (40 cycles). Calculated thresholds were determined using the maximum-curvature approach after determination of per-well
baseline cycles (iCycler; Bio-Rad). The amplified DNA samples were further
subjected to melting-curve analysis and 1.2% agarose gel electrophoresis to
verify the amplification product. Relative quantities of target ORF transcripts
were calculated using the cycle threshold (CT) values of the housekeeping gene,
sigA (Rv2703), as an internal standard as described previously (12, 23).
Microarray hybridization. The Institute for Genomic Research (Pathogen
Functional Genomics Resource Center [http://www.tigr.org]) provided the
Mycobacterium tuberculosis genome microarray for this study. The genome microarray consisted of 70-mer oligonucleotides representing 4,127 ORFs from the
M. tuberculosis reference strain H37Rv and 623 unique ORFs from strain
CDC1551 that are not present in the H37Rv strain’s annotated gene complement
(98% of H37Rv ORFs). The full 70-mer complement was printed four times on
the surface of the microarray. Total M. tuberculosis RNA was isolated using a
TRIzol (Invitrogen) extraction and RNeasy (QIAGEN) purification as described
previously (32). Two-color (Cy3 and Cy5) hybridization was used for the microarray analysis. Generally, RNA extracted from cells growing exponentially at
an optical density (A600) of approximately 0.5 in Middlebrook 7H9 medium (pH
7.0) was used to create fluorescent Cy3-labeled reference cDNA for each experiment (mid-log phase). The reference Cy3-labeled cDNA was hybridized together with the Cy5-labeled cDNA synthesized from RNA extracted from cells
when the optical density was approximately doubled (late-log phase). Labeled
cDNA was prepared as follows. Ten micrograms of total RNA and 2 g of
random oligonucleotide hexamers (Invitrogen, CA) were incubated for 15 min at
65°C, cooled on ice, combined with Stratascript reverse transcriptase buffer, 0.5
mM dATP, 0.5 mM dGTP, 0.5 mM dCTP, 0.02 mM dUTP, 1.5 nmol aminoallyldUTP (Amersham, NJ), and 2 l Stratascript reverse transcriptase II (Invitrogen, CA) in a total volume of 30 l. This mixture was incubated for 10 min at
room temperature and at 42°C overnight. Synthesized cDNA was purified with a
QIAquick PCR purification kit (QIAGEN, CA) according to the manufacturer’s

recommendations. The aminoallyl-dUTP-conjugated cDNA probes were spin
dried (SpeedVac; Savant) and resuspended in 50 mM sodium carbonate buffer
(pH 9.3) and cyanine monofunctional dyes (Amersham) for 1 h at room temperature, followed by quenching with 4 M hydroxylamine. The cyanine-labeled
probes were purified again with a QIAquick PCR purification kit. All hybridizations were performed with dye reversal replicates. QuantArray (version 3.0;
Perkin-Elmer) was used for 16-bit TIFF image quantification and initial data
visualization. The hybridization signal was subjected to normalization and clustering by using an open-source R (version 2.1.1) package (http://www
.bioconductor.org/).
Recombinant-protein expression and preparation of cell extracts. The ORF
for ␤6 (accD6; Rv2247) was cloned by PCR using Pfu Turbo HotStart DNA
polymerase (Stratagene) from the genomic DNA of M. tuberculosis H37Rv. The
expression construct was prepared in pET 200 directional-TOPO expression
vector (Invitrogen), and sequence integrity was confirmed by DNA sequencing.
BL21 Star (DE3) host cells were transformed with the expression construct, and
the overnight culture was diluted 1:50 in fresh medium. IPTG (isopropyl-␤-Dthiogalactopyranoside) was added to a final concentration of 1 mM when the
culture reached an optical density at 600 nm (OD600) of 0.7, and the induction
was carried out for 4 h in a 37°C shaker. The ␣3 subunit was expressed and
biotinylated with the E. coli biotin ligase as described previously (22). Following
induction, the cells were washed and resuspended in lysis buffer (50 mM sodium
phosphate, 300 mM NaCl, 1 mM phenylmethylsulfonyl fluoride). The cells were
disrupted by sonication using a Branson Sonifier 450 (Branson Ultrasonics
Corp.). The cell lysates were clarified by centrifugation at 12,000 ⫻ g, and the
supernatants were used for purification of the expressed proteins. The ␤5
(Rv3280) and ε (Rv3281) subunits were expressed in E. coli as described previously (22).
Purification, SDS-PAGE analysis, and dialysis of expressed proteins. The
clear supernatants obtained from the above-mentioned lysates were applied to
TALON cobalt affinity resin (BD Biosciences), and the His-tagged ␤6 and ␣3
(after biotinylation) were purified by the batch/gravity procedure of the manufacturer with the following modifications: the bound proteins were washed with
10 mM imidazole and eluted from the affinity resin with 100 mM imidazole and
500 imidazole elution steps. The eluted fractions were analyzed by 10% sodium
dodecyl sulfate-polyacrylamide gel electrophoresis (SDS-PAGE), and fractions
containing pure protein were pooled and dialyzed against 100 mM potassium
phosphate (pH 8.0) containing 10% glycerol at 4°C. The ␤5 and ε subunits were
purified as described previously (22).
Reconstitution of the carboxylase complex. Following dialysis, the purified ␣3
subunit (100 g/ml) was mixed with the purified ␤6 subunit (100 g/ml), and the
purified ␣3, ␤6, and ε subunits were mixed together in a 1:1:2 molar ratio and
incubated on ice for 6 h. Following this, the solutions were concentrated four- to
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sixfold by ultrafiltration in Centriprep YM-10 filters (Millipore) at 700 ⫻ g for 4 h
at 4°C and used in the carboxylase assay.
Acyl-CoA carboxylase assay. The carboxylase activity of the reconstituted
␣3-␤6 complex was measured by following the incorporation of the radiolabel
from NaH14CO3 into acid-stable reaction product using a modified procedure of
Hunaiti and Kolattukudy (15). The reaction was carried out in a 100-l volume
containing 100 mM potassium phosphate, pH 8.0, 300 g bovine serum albumin,
3 mM ATP, 5 mM acetyl-CoA or propionyl-CoA, 5 mM NaH14CO3, 5 mM
MgCl2, and 20 to 30 g of reconstituted enzyme. Following incubation at 30°C
for 2 h, the reaction was stopped with 150 l of 6 M HCl, and the entire solution
was evaporated to dryness in a heating block at 100°C. The residue was resuspended in 100 l water, and the radioactivity was measured by liquid scintillation
counting. The effects of inhibitors were determined by preincubating the reconstituted ␣3-␤6 complex with the inhibitor for 10 min at 24°C, after which the
percent inhibition above the respective solvent control was determined. The
kinetic parameters for the ␣3-␤6 carboxylase were calculated using nonlinear
regression analysis with the Michaelis-Menten equation, and the 50% inhibitory
concentrations (IC50s) were determined from the sigmoidal dose-response equation (GraphPad Prism version 3.02; GraphPad Software).
Microarray accession number. The data discussed in this publication have
been deposited in NCBI’s Gene Expression Omnibus (GEO [http://www.ncbi
.nlm.nih.gov/geo/]) and are accessible through GEO Series accession number
GSE5977.

RESULTS
Analysis of carboxylase subunit transcript levels. To determine which of the multiple carboxylase subunit genes are actually expressed in M. tuberculosis, we analyzed the expression
levels of all of the ORFs encoding the carboxylase subunits by
qPCR and microarray analyses. RNA isolated from cells at
exponential growth phase was subjected to qPCR, and each CT
value was normalized to the level of the internal control sigA
qPCR CT value as described previously (12, 23). By comparison with the normalized CT values of sigA, we determined the
relative levels of expression of the ACC subunits during exponential growth of M. tuberculosis. The results showed that the
levels of expression of the ␤4, ␤5, ␤6, and ε subunits were
highest among the carboxylase subunit ORFs when the mycobacterial cells were in exponential growth phase (Fig. 1). ␣3
was the most highly expressed gene among the acyl-CoA carboxylase ␣-subunit ORFs. To monitor gene expression changes
during cell growth, independent batches of cells were subjected
to microarray analysis. Comparison of transcription profiles
obtained at various growth stages indicated that the ␣3, ␤4, ␤5,
␤6, and ε ORFs were the most significantly repressed subunits

FIG. 2. Expression levels of carboxylase subunits during normal M.
tuberculosis growth. Wild-type M. tuberculosis was grown in 7H9 complete medium (pH 7.0; 37°C) under normal aeration in a rolling culture
tube. The cells were harvested at OD600s of 0.53 (after 6 days of
inoculation; “Mid-log”), 1.17 (after 8 days; “Late-log”), and 1.42 (after
12 days; “Stationary”). The total RNA was isolated and hybridized on
DNA oligonucleotide microarrays as described in Materials and Methods. The hybridization signals were subjected to scale print tip median
absolute deviation and quantile normalization (34). The relative expression level change for each acyl-CoA carboxylase subunit was obtained by comparing mid-log growth phase as a reference signal at
late-log and stationary growth phases. The error bars indicate standard
deviations.

among all the acyl-CoA carboxylase ORFs as the mycobacterial cells transitioned from mid-log to late-log and stationary
phases (Fig. 2), while the levels of transcripts for other ACC
subunits did not change much.
Purification of ␣3 and ␤6 subunits. Although the ␤6 (accD6)
ORF is located within a cluster of genes encoding FAS II
components (Fig. 3) which have been shown to be involved in
mycolic acid biosynthesis (28), the enzymatic activity of ␤6 has
never been investigated. Since ␤6 was reported to be essential
for the viability of M. tuberculosis, along with ␣3, ␤4, and ε
subunits (26), and there is no ␣ subunit in the genetic neighborhood of ␤6, we deduced that the ␣3-␤6 complex might
constitute a functional acyl-CoA carboxylase. To investigate
the carboxyltransferase activity of ␤6, we expressed ␤6 and ␣3
as His-tagged fusion proteins in E. coli and purified them by
cobalt affinity chromatography. The ␣3 subunit was biotinylated using the E. coli biotin ligase prior to purification as
described previously (22). The fractions eluted from the
TALON resin were analyzed on SDS-PAGE (Fig. 4), and the
fractions containing pure protein were used for reconstitution

FIG. 3. Genetic locus of AccD6 (␤6) in pathogenic mycobacteria.
The gene numbers and the amino acid identities of the respective
AccD6 subunits are indicated. AccA3, acetyl/propionyl-CoA carboxylase (␣3 subunit); AccD6, acetyl/propionyl-CoA carboxylase (␤6 subunit); FabD, malonyl-ACP transacylase.
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FIG. 1. Quantitative real-time PCR analysis of acyl-CoA carboxylase
gene expression in exponentially growing cultures of M. tuberculosis. Total
RNA was prepared from mid-log-phase cultures of M. tuberculosis H37Rv
(OD600 ⫽ 0.5). The transcript level of each acyl-CoA carboxylase subunit
is indicated relative to the expression level of sigA as an internal control.
Values represented are means and standard errors.
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DISCUSSION
FIG. 4. Purification of M. tuberculosis ␣3 and ␤6 subunits expressed
in E. coli. Fractions eluted from the cobalt affinity resin were analyzed
by 10% SDS-PAGE, followed by Coomassie staining. Representative
fractions containing pure subunits used in assays are shown. Prior to
purification, ␣3 was biotinylated using E. coli biotin ligase. MW, molecular weight standards.

of the acyl-CoA carboxylase. The ε and ␤5 subunits were purified as described previously (22).
Reconstitution and characterization of the enzymatic activity of ␣3-␤6 carboxylase. Following dialysis, the ␣3 and ␤6
subunits were mixed together in a 1:1 molar ratio, and the
reconstituted ␣3-␤6 complex was assayed for acyl-CoA carboxylase activity. The ␣3-␤6 complex carboxylated acetyl-CoA with
high specific activity (1.1 nmol/mg/min) and propionyl-CoA at
lower levels (0.36 nmol/mg/min). The activity increased linearly with time and protein concentration (Fig. 5A and B) and
displayed typical Michaelis-Menten kinetics for bicarbonate
(Fig. 5C), acetyl-CoA and propionyl-CoA (Fig. 5D), and ATP
(Fig. 5E). Under the assay conditions, saturation was reached
with 2 mM bicarbonate, 5 mM acetyl-CoA or 2.5 mM propionyl-CoA, and 0.5 mM ATP. The optimal MgCl2 concentration
was 10 mM for acetyl-CoA carboxylase (ACC) activity and 5
mM for propionyl-CoA carboxylase (PCC) activity. The kinetic
parameters for the ␣3-␤6 complex are tabulated in Table 2.
Effects of inhibitors on ␣3-␤6. The carboxylase activities of
␣3-␤6 were inhibited by avidin and several other inhibitors. As
shown in Table 3, at 100 M, dimethyl itaconate and C75
inhibited the ACC activity of ␣3-␤6 by 96% and 87%, respectively, and the PCC activity by 53% and 54%, respectively.
Haloxyfop, cerulenin, and 1,2-cyclohexanedione inhibited the
enzymatic activities significantly. The dose dependence of inhibition by dimethyl itaconate and C75 of the ACC and PCC
activities of ␣3-␤6 was investigated, and the results are shown in
Fig. 6. From this sigmoidal dose-response analysis, the IC50s
for dimethyl itaconate were calculated to be 8.2 M for ACC
and 10.8 M for PCC. For C75, the IC50s were 50.2 M for
ACC and 101.5 M for PCC.
Effect of the epsilon subunit on the ␣3-␤6 complex and
stoichiometry of the ␣3-␤6 carboxylase. We examined the ef-

Mycolic acid biosynthesis in M. tuberculosis involves FAS I,
which carries out the de novo synthesis of C16-C26 fatty acids
(16), and the FAS II multisubunit complex, which is incapable
of de novo fatty-acid biosynthesis but elongates C14 and C16
primers to produce meromycolates (28). The FAS II complex
in M. tuberculosis is located in a genetic locus that also contains
a lone, uncharacterized acyl-CoA carboxylase carboxyltransferase subunit, accD6 (␤6) (6), which could provide malonylCoA to the ␤-ketoacyl-ACP synthases and to FAS I. MalonylCoA is converted to malonyl-ACP by the malonyl-CoA-ACP
transacylase (FabD) (19) and is utilized by the ␤-ketoacyl-ACP
synthases (KasA/KasB) (5, 18, 27) in successive reactions with
the other enzymes of the FAS II complex to produce the
meromycolic acids. Protein-protein interaction analyses have
shown that FabD is a structural component of the FAS II
complex (30) and that KasA, KasB, InhA, MabA (FabG1), and
FabH (␤-ketoacyl-ACP synthase III) interact with each other
(31).
The reconstituted ␣3-␤6 acyl-CoA carboxylase, reported
here, preferred acetyl-CoA over propionyl-CoA, in contrast to
the ␣3-␤5 complex, which preferred propionyl-CoA over
acetyl-CoA (10, 22). This observation leads us to suggest that
M. tuberculosis may utilize the ␤6 subunit with ␣3 to provide
malonyl-CoA to FAS I and to the FAS II complex for de novo
fatty-acid biosynthesis and mycolic acid biosynthesis, respectively, and the ␤5 subunit with ␣3 for providing methylmalonylCoA for branched-fatty-acid biosynthesis. The rate of acetylCoA carboxylation by the ␣3-␤5 complex increased when the ε
subunit was bound to it (10, 22), and thus, the ␣3-␤5-ε complex
could also provide malonyl-CoA for fatty-acid biosynthesis in
mycobacteria. The ␣3 subunit also interacts with the ␤4
(AccD4) subunit, which is possibly involved in the carboxylation of fatty acids that may then be incorporated into mycolic
acids (11, 22, 24).
Isoniazid was shown to inhibit the biosynthesis of mycolic
acids (29), and the reductases involved in fatty-acid elongation
isolated from Mycobacterium avium were shown to be selectively inhibited by the drug (17). More recent work has shown
that the reductases are the targets of isoniazid inhibition in M.
tuberculosis (1, 25). In isoniazid-treated M. tuberculosis cul-
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fect of the epsilon (ε) subunit on the activity of the ␣3-␤6
complex. In our previous report on the effect of the ε subunit
on the carboxylase activities of the ␣3-␤5 complex, we determined that the optimal molar ratio of ␣3 to ␤5 to ε was 1:1:2
(22). Therefore, we incubated the ␣3, ␤6, and ε subunits together at the same molar ratio of 1:1:2 prior to assay. As shown
in Fig. 7, the ε subunit inhibited both the ACC and PCC
activities of the ␣3-␤6 complex. However, the ε subunit stimulated the ACC and PCC activities of the ␣3-␤5 complex, as
reported previously (reference 22 and data not shown). We
analyzed the stoichiometry of the reconstituted ␣3-␤6 carboxylase by gel filtration chromatography on Sepharose CL-6B
(a 1,100-mm by 5-mm column equilibrated with 50 mM potassium phosphate buffer, pH 7.0, and 50 mM NaCl). The reconstituted ␣3-␤6 complex eluted in a peak with the apparent
molecular mass of a dodecamer comprising six molecules each
of the ␣3 and ␤6 subunits (data not shown).
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tures, the accD6 ORF was upregulated, along with the other
FAS II complex members in its neighborhood, which have
been shown to be involved in mycolic acid biosynthesis (33).
The ␤6 subunits of other pathogenic mycobacteria, Mycobacterium leprae and Mycobacterium bovis, show a high degree
of identity (93% and 100%, respectively) with the M. tubercu-

TABLE 2. Kinetic parameters for the acyl-CoA carboxylase
␣3-␤6 of M. tuberculosisa
ACC

PCC

Substrate

Acetyl-CoA
Propionyl-CoA
NaHCO3
ATP

Vmax

Km

SC

Vmax

Km

SC

1.1
NA
0.61
0.67

4.9
NA
0.68
0.12

0.22
NA
0.9
5.6

NA
0.36
0.43
0.34

NA
0.97
0.66
0.06

NA
0.37
0.65
5.67

a
Vmax, nmol/mg/min; Km, mM; SC, specificity constant (Vmax/Km); NA, not
applicable.

TABLE 3. Effects of inhibitors on the carboxylase activities of the
reconstituted M. tuberculosis ␣3-␤6 complex
% Inhibitiona
Inhibitor

Avidin
Dimethyl itaconate
C75
Haloxyfop
Cerulenin
1,2-Cyclohexanedione
Diclofop
Alloxydim
5-(Tetradecyloxy)-2-furoic acid
5-Iodotubericidin

ACC

PCC

93 ⫾ 0.1
96 ⫾ 5
87 ⫾ 16
60 ⫾ 4
54 ⫾ 20
40 ⫾ 23
13 ⫾ 3
11 ⫾ 3
8 ⫾ 0.7
0

94 ⫾ 0.7
53 ⫾ 4
54 ⫾ 12
53 ⫾ 8
31 ⫾ 10
45 ⫾ 11
9⫾6
20 ⫾ 9
0
28 ⫾ 5

a
The ␣3-␤6 complex was preincubated with 1 unit avidin (binds 1 g D-biotin)
or 100 M inhibitor and used in the assay. Percent inhibition above the respective solvent control is given as mean ⫾ standard deviation from three independent assays of the carboxylase with inhibitor.
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FIG. 5. Kinetic characterization of the reconstituted ␣3-␤6 acyl-CoA carboxylase of M. tuberculosis. The time course (A) and protein dependence (B) of ACC (■) and PCC (e) activities are shown. The dependence of carboxylase activity on the concentrations of bicarbonate (C),
acyl-CoA (D), ATP (E), and MgCl2 (F) was determined by measuring acid-stable radioactivity following carboxylation with NaH14CO3. Values
represented are means and standard errors.
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FIG. 6. Inhibition of acyl-CoA carboxylase activities of ␣3-␤6 by
dimethyl itaconate and C75. Inhibitions by dimethyl itaconate of ACC
(■) and PCC (e) activities (A) and by C75 of ACC (Œ) and PCC (‚)
activities (B) were measured after preincubation of the respective
inhibitor at the indicated concentrations with reconstituted ␣3-␤6 for
10 min at 24°C prior to the carboxylase assay. Percent inhibition above
the solvent (dimethyl sulfoxide) control was plotted as the mean with
standard deviation.

losis ␤6 subunit (6, 7, 13). Since ␤6 is predicted to be an
essential gene (26), it may not be possible to disrupt the gene
to show a direct biochemical consequence. Our current and
previous observations showed that the ␣3, ␤4, ␤5, and ␤6 ORFs
are highly expressed in M. tuberculosis and that their products
have catalytic activities (22). Interestingly, M. leprae, which has
lost a significant portion of its genome, has retained only ␣3,
␤4, ␤5, and ␤6 as functional ORFs among the ACC-encoding
ORFs in its genome (7).
Our microarray results indicated that the transcripts for the
␣3, ␤4, ␤5, ␤6, and ε subunits were repressed as mycobacterial
cells entered late log phase, when they possibly begin to encounter unfavorable growth conditions, like nutrient starvation, suggesting that these carboxylase subunits may be less
important for the mycobacterium during the late-log and stationary growth phases. The inhibition of the carboxylase activities of the ␣3-␤6 complex when reconstituted with the ε subunit indicated that the ε subunit hindered interaction between
the ␣3 and ␤6 subunits. Analysis of the stoichiometry of the
␣3-␤6 complex indicated that it is reconstituted as a dodecamer
containing six molecules each of the ␣3 and ␤6 subunits, similar
to the ␣3-␤5 complex, which was reported to exist as a dodecamer (10).
Inhibitors that were previously shown to target a particular
enzyme have subsequently been demonstrated to inhibit novel
targets. C75 is a synthetic inhibitor of fatty acid synthase and is
a potential antiobesity and antitumor drug (20). C75-CoA was

recently shown to inhibit carnitine palmitoyl transferase I in a
novel mode of action (3). In another example, itaconate, which
is a potent inhibitor of isocitrate lyase, was shown to inhibit
propionyl-CoA carboxylase in cell extracts of Rhodospirillum
rubrum (4). Isocitrate lyase is a glyoxylate shunt pathway enzyme that is used by M. tuberculosis to utilize fatty acids as a
carbon source (21). Therefore, we investigated the effects of
several inhibitors that have been shown to inhibit fatty-acid
metabolism but had not been shown to inhibit ACC activity.
Interestingly, we found that C75 and dimethyl itaconate severely inhibited the carboxylase activities of ␣3-␤6 in our assays
(Fig. 6). Further work on the mechanism of action of these
inhibitors is needed, and the characterization of such inhibitors, which target multiple biochemical pathways, may lead to
the identification of potent drug candidates against M. tuberculosis.
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